Literature DB >> 9406654

Measles virus-specific immunoglobulin G subclass response in serum and cerebrospinal fluid.

M Narita1, S Yamada, Y Matsuzono, O Itakura, T Togashi, H Kikuta.   

Abstract

BACKGROUND: While many previous studies have focused on the impairment in the cellular immunity during measles virus infection, to date, a limited amount of data is available concerning the virus-specific IgG subclass response during measles virus infection.
OBJECTIVE: The purpose of this study is to analyze the measles virus infection on the basis of virus-specific IgG subclass (G 1 and G 3). STUDY
DESIGN: Frozen-stored, serum and/or cerebospinal fluid samples from three groups of patients were tested retrospectively; Group 1 comprised 14 patients with measles primary infection, group 2, ten patients with reinfection/vaccine failure, and group 3, seven patients with subacute sclerosing panencephalitis. The method used was a modified ELISA method utilizing the Enzygnost IgG detection kit with mouse-monoclonal antibodies (clone HP6091 for IgG 1 and clone HP6050 for IgG 3). Avidity testing for each subclass IgG was also performed for selected samples by means of an 8 M urea-denaturation method.
RESULTS: In group 1, the IgG 3 could be detected in serum within 7 days from the onset of rash more frequently than IgG 1. In the cases of group 2, both subclasses were detected in very acute phase serum samples. In these cases, the IgG 1-specific avidity was always higher than that of IgG 3. In group 3, the subclass IgGs detected in the cerebrospinal fluid had a lower avidity than those in the serum.
CONCLUSIONS: Our results suggested that in measles virus infection, like other viral infections, the IgG 3 response normally occurs before the IgG 1 response, and plays a major role in the acute phase immunity during the primary infection, while the IgG 1 plays a major role in the maintenance of immunity. Continuously produced IgG 1 and IgG 3 in the central nervous system in cases of subacute sclerosing panencephalitis may be derived from cell populations different from those in the blood.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406654     DOI: 10.1016/s0928-0197(97)10007-1

Source DB:  PubMed          Journal:  Clin Diagn Virol        ISSN: 0928-0197


  6 in total

1.  Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.

Authors:  Anna P Toptygina; Alexander L Pukhalsky; Vladimir A Alioshkin
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

2.  Measles virus-specific immunoglobulin G isotype immune response in early and late infections.

Authors:  M B Isa; L Martínez; M Giordano; M Zapata; C Passeggi; M C De Wolff; S Nates
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection.

Authors:  J Xu; P Dennehy; H Keyserling; L E Westerman; Y Wang; R C Holman; J R Gentsch; R I Glass; B Jiang
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

4.  Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection.

Authors:  Yiu-Wing Kam; Diane Simarmata; Angela Chow; Zhisheng Her; Terk-Shin Teng; Edward K S Ong; Laurent Rénia; Yee-Sin Leo; Lisa F P Ng
Journal:  J Infect Dis       Date:  2012-03-01       Impact factor: 5.226

5.  Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.

Authors:  Sumi Biswas; Prateek Choudhary; Sean C Elias; Kazutoyo Miura; Kathryn H Milne; Simone C de Cassan; Katharine A Collins; Fenella D Halstead; Carly M Bliss; Katie J Ewer; Faith H Osier; Susanne H Hodgson; Christopher J A Duncan; Geraldine A O'Hara; Carole A Long; Adrian V S Hill; Simon J Draper
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

6.  Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.

Authors:  Kenneth B Lewis; Richard J Hughes; Melinda S Epstein; Neil C Josephson; Christine L Kempton; Craig M Kessler; Nigel S Key; Tom E Howard; Rebecca Kruse-Jarres; Jeanne M Lusher; Christopher E Walsh; Raymond G Watts; Ruth A Ettinger; Kathleen P Pratt
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.